Lakefront Biotherapeutics (LKFT) Other financing activities (2014 - 2017)

Lakefront Biotherapeutics (LKFT) has 3 years of Other financing activities data on file, last reported at $7.7 million in Q4 2017.

• Other financing activities for Q4 2017 came in at $7.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $14.6 million (changed N/A YoY), and the FY2017 annual result was $7.7 million, changed N/A from the prior year.
• Other financing activities rose to $7.7 million in Q4 2017 per LKFT's latest filing, from -$91654.9 in the prior quarter.
• Over five years, Other financing activities peaked at $7.7 million in Q4 2017 and troughed at -$9.3 million in Q4 2014.
• A 3-year average of $1.6 million and a median of $2.5 million in 2015 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 126.68% in 2015 and fell as far as 126.68% in 2015.
• A 3-year view of Other financing activities shows it stood at -$9.3 million in 2014, then soared by 126.68% to $2.5 million in 2015, then jumped by 210.7% to $7.7 million in 2017.
• Business Quant data shows LKFT's Other financing activities at $7.7 million in Q4 2017, -$91654.9 in Q3 2017, and $7.0 million in Q1 2017.